Thomas Hecking

Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy

Yuri Tolkach, Heidrun Gevensleben, Ralph A. Bundschuh et al. · Breast Cancer Research and Treatment · 2018 · 75 citations

Medicine, Nuclear Medicine, Oncology +17

Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology

Thomas Hecking, Thore Thiesler, J. Lunkenheimer et al. · Oncotarget · 2017 · 53 citations · Full text

Medicine, Oncology, Pathology +17

Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers

Ramona Dolscheid‐Pommerich, Mignon Keyver-Paik, Thomas Hecking et al. · Tumor Biology · 2017 · 34 citations · Full text

Medicine, Gynecology, Oncology +17

Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer

Thomas Hecking, Thore Thiesler, Janina Halbe et al. · Anticancer Research · 2022 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian Cancer.

Mignon-Denise Keyver-Paik, Janne Myriam Arden, Christine Lüders et al. · PubMed · 2016 · 11 citations

Medicine, Oncology, Surgery +17